Evidence map›Paper›PMID 32940821›Full record

ReviewMolecular and cellular biochemistry2021

Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension.

Morris Karmazyn, Xiaohong Tracey Gan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular and cellular biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 52 citations in OpenAlex.

  1. Ginsenoside Rg2 fromMolecules (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Article
  4. Journal of ginseng research · 2025
    Review
  5. Article
  6. Review
  7. Ginsenoside RbChinese herbal medicines · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Current computer-aided drug design · 2024
    Article
  14. Cucumber (Journal of pharmacopuncture · 2023
    Article
  15. Influence ofFoods (Basel, Switzerland) · 2023
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. CanJournal of ginseng research · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Morris KarmazynUniversity of Western Ontario, London, ON, N6G 2X6, Canada. morriskarmazyn@gmail.com.ORCID http://orcid.org/0000-0002-4904-5985
Xiaohong Tracey GanUniversity of Western Ontario, London, ON, N6G 2X6, Canada.
Western University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginseng is an ancient perennial herb belonging to the family Araliaceae and genus Panax which has been used for medical therapeutics for thousands of years, particularly in China and other Asian cultures although increasing interest in ginseng has recently emerged in western societies. Ginseng is a complex substance containing dozens of bioactive and potentially effective therapeutic compounds. Among the most studied are the ginsenosides, which are triterpene saponins possessing a wide array of potential therapeutic effects for many conditions. The quantity and type of ginsenoside vary greatly depending on ginseng species and their relative quantity in a given ginseng species is greatly affected by extraction processes as well as by subjecting ginseng to various procedures such as heating. Adding to the complexity of ginsenosides is their ability to undergo biotransformation to bioactive metabolites such as compound K by enteric bacteria following ingestion. Many ginsenosides exert vasodilatating effects making them potential candidates for the treatment of hypertension. Their vascular effects are likely dependent on eNOS activation resulting in the increased production of NO. One proposed end-mechanism involves the activation of calcium-activated potassium channels in vascular smooth cells resulting in reduced calcium influx and a vasodilatating effect, although other mechanisms have been proposed as discussed in this review.

Indexed as

AnimalsAntihypertensive AgentsAraliaceaeBiotransformationBlood PressureCalciumChinaFermentationGinsenosidesHot TemperatureHumansHypertensionModels, AnimalMuscle, Smooth, VascularNitric Oxide Synthase Type IIIPanaxAntihypertensive AgentsCalciumGinsenosidesNitric Oxide Synthase Type IIINOS3 protein, humanPolysaccharidesSaponinsTriterpenesCompound KGinsengGinsenosidesHypertensionNitric oxideVasodilatation

Identifiers

PMID32940821
OpenAlexW3085903124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.